Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Pharmacist Recommendations Reduce Medication-Related Harm
09/07/2021
Maria Asimopoulos
“Clinic pharmacists in multidisciplinary outpatient clinics are effective at identifying and resolving medication-related problems,” study authors wrote.
“Clinic pharmacists in multidisciplinary outpatient clinics are effective at identifying and resolving medication-related problems,” study authors wrote.
“Clinic pharmacists in...
09/07/2021
Pharmacy Learning Network
News
From Uber Rides to Patient Advocates: What It Takes to Increase ER Addiction Treatment
09/03/2021

Aneri Pattani, Kaiser Health News

Aneri Pattani, Kaiser Health News ...
Despite widespread consensus on the importance of addiction treatment in the ER, many hospitals fail to screen for substance use, offer medications to treat opioid use disorder, or connect patients to follow-up care.
Despite widespread consensus on the importance of addiction treatment in the ER, many hospitals fail to screen for substance use, offer medications to treat opioid use disorder, or connect patients to follow-up care.
Despite widespread consensus on...
09/03/2021
Pharmacy Learning Network

Advertisement

News
Mislabeling of Drug Autoinjector Prompts Recall
09/03/2021
Jolynn Tumolo
A labeling error has prompted Eli Lilly & Company to recall a prescription medication used to help control high blood sugar in people with type 2 diabetes.
A labeling error has prompted Eli Lilly & Company to recall a prescription medication used to help control high blood sugar in people with type 2 diabetes.
A labeling error has prompted...
09/03/2021
Pharmacy Learning Network
News
Class I Recall for Contaminated IV Bags
09/03/2021
Jolynn Tumolo
A Class I recall is active for a prescription treatment indicated for patients with high potassium, irregular heartbeat, or metabolic acidosis.
A Class I recall is active for a prescription treatment indicated for patients with high potassium, irregular heartbeat, or metabolic acidosis.
A Class I recall is active for a...
09/03/2021
Pharmacy Learning Network
News
Class I Recall for Antifungal Medication
09/03/2021
Jolynn Tumolo
A voluntary recall initiated by KVK Tech Inc for two lots of atovaquone oral suspension has been designated Class I by the FDA.
A voluntary recall initiated by KVK Tech Inc for two lots of atovaquone oral suspension has been designated Class I by the FDA.
A voluntary recall initiated by...
09/03/2021
Pharmacy Learning Network

Advertisement

News
Muscle Relaxant Recalled
08/26/2021
Jolynn Tumolo
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II...
08/26/2021
Pharmacy Learning Network
News
Dietary Supplement Contains Hidden Statin, FDA Warns
08/26/2021
Jolynn Tumolo
The FDA is warning consumers to avoid the dietary supplement Cholestene because it contains lovastatin, the active ingredient in the FDA-approved prescription drug Mevacor.
The FDA is warning consumers to avoid the dietary supplement Cholestene because it contains lovastatin, the active ingredient in the FDA-approved prescription drug Mevacor.
The FDA is warning consumers to...
08/26/2021
Pharmacy Learning Network
News
Beta Blocker Recalled
08/26/2021
Jolynn Tumolo
A Class II recall is active for a prescription medication used to treat high blood pressure and heart failure.
A Class II recall is active for a prescription medication used to treat high blood pressure and heart failure.
A Class II recall is active for...
08/26/2021
Pharmacy Learning Network

Advertisement

News
Prenatal Care and Pharmacy: Examining Prenatal Vitamin Recommendations Given by Community Pharmacists
08/19/2021
Julie Gould
“Considering the broad range of prenatal vitamins on the market, a clear recommendation from a pharmacist about a specific prenatal vitamin that contains adequate nutrients is paramount,” stressed the authors of a recent study.
“Considering the broad range of prenatal vitamins on the market, a clear recommendation from a pharmacist about a specific prenatal vitamin that contains adequate nutrients is paramount,” stressed the authors of a recent study.
“Considering the broad range of...
08/19/2021
Pharmacy Learning Network
News
Is Internet-based Medication Information Provided by Patients Beneficial for Pharmacists?
08/19/2021
Julie Gould
Researchers recently aimed to better understand pharmacist experience linked with the use of internet-based medication provided by their patients.
Researchers recently aimed to better understand pharmacist experience linked with the use of internet-based medication provided by their patients.
Researchers recently aimed to...
08/19/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use